Extension Study of IDEAL (Imatinib) for Chronic Myelgenous Leukemia (CML)
Gleevec as Maintenance Therapy After Cytogenetic Response With Nilotinib in Newly Diagnosed Chronic Myelogenous Leukemia
Safety of Zileuton (Zyflo) in Combination With Imatinib Mesylate (Gleevec) in CML.
Allogeneic Stem Cell Transplantation in CML With Partial T Cell Depletion
STI571 Compared With Interferon Alfa Plus Cytarabine in Treating Patients With Newly Diagnosed Chronic Myelogenous Leukemia
† Indicates status has not been verified in more than two years